Preferred Label : Albinism, oculocutaneous, type ib;
Symbol : OCA1B;
CISMeF acronym : OCA1B;
Type : Phenotype, molecular basis known;
Alternative titles and symbols : Oculocutaneous albinism, type ib; Albinism, yellow mutant type; Yellow albinism;
Included titles and symbols : Albinism, oculocutaneous, type I, temperature-sensitive; Oca1-ts;
Description : Oculocutaneous albinism type I is an autosomal recessive disorder characterized by
absence of pigment in hair, skin, and eyes, and does not vary with race or age. Severe
nystagmus, photophobia, and reduced visual acuity are common features. OCA type I
is divided into 2 types: type IA, characterized by complete lack of tyrosinase activity
due to production of an inactive enzyme, and type IB, characterized by reduced activity
of tyrosinase. Although OCA caused by mutations in the TYR gene was classically known
as 'tyrosinase-negative' OCA, Tripathi et al. (1992) noted that some patients with
'tyrosinase-positive' OCA may indeed have TYR mutations resulting in residual enzyme
activity. These patients can be classified as having OCA1B.;
Inheritance : Autosomal recessive;
Molecular basis : Caused by mutation in the tyrosinase gene (TYR, 606933.0002);
Prefixed ID : #606952;
Origin ID : 606952;
UMLS CUI : C1847024;
Automatic exact mappings (from CISMeF team)
Broader ORDO disease(s)
Currated CISMeF NLP mapping
DO Cross reference
Genes related to phenotype
HPO term(s)
ORDO concept(s)
Semantic type(s)
UMLS correspondences (same concept)